BRAXF News and Press, Braxia Scientific Corp From 07/07/21

Braxia Scientific to Discuss Psychiatric Treatment Discovery and Development with Oxford University Researchers at AIMday Experimental Medicine in Psychiatry on July 7, 2021 Canada NewsWire TORONTO , July 7, 2021 /CNW/ - Braxia Scientific Corp. ("Braxia", or...

Braxia Scientific Announces Participation at PSYCH Investor Summit on July 7, 2021 Canada NewsWire TORONTO , July 6, 2021 /CNW/ - Braxia Scientific Corp. ("Braxia", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 496), a medical research company with clinics pr...

Braxia Scientific Launches Psilocybin-Assisted Clinical Therapy Training Program to Develop New Generation of Qualified Physicians, Psychotherapists and Psychologists for Mental Health Canada NewsWire TORONTO , June 29, 2021 /CNW/ - Braxia Scientific Corp. ("Brax...

/R E P E A T -- Braxia Scientific Awarded Government of Canada Funding to Complete First of its Kind Ketamine Clinical Trial for Bipolar Depression/ Canada NewsWire Fully funded by the Canadian Institute of Health Research (CIHR), this multi-site clinical trial will ta...

Braxia Scientific (BRAXF) has been awarded funding by the Canadian Institute of Health Research ((CIHR)), of the Government of Canada, to support the first of its kind Ketamine clinical trial for Bipolar Depression.The fully funded study will investigate the use, safety and efficacy of r...

Braxia Scientific Awarded Government of Canada Funding to Complete First of its Kind Ketamine Clinical Trial for Bipolar Depression Canada NewsWire Fully funded by the Canadian Institute of Health Research (CIHR), this multi-site clinical trial will take place at Tor...

/R E P E A T -- Braxia Scientific to Present at the Psychedelics in Psychiatry and Beyond Virtual Conference Hosted by H.C. Wainwright & Co. on June 17, 2021/ /R E P E A T -- Braxia Scientific to Present at the Psychedelics in Psychiatry and Beyond Virtual Conference Hosted ...

Braxia Scientific to Present at the Psychedelics in Psychiatry and Beyond Virtual Conference Hosted by H.C. Wainwright & Co. on June 17, 2021 Braxia Scientific to Present at the Psychedelics in Psychiatry and Beyond Virtual Conference Hosted by H.C. Wainwright & Co. on J...

American Journal of Psychiatry Publishes International Ketamine and Esketamine Treatment Guidance Led by Braxia Scientific CEO Dr. Roger Mcintyre Canada NewsWire International Expert Opinion and Implementation Guidance outlines Ketamine and Esketamine treatment param...